about
Role of cytochrome P450 in drug interactionsMolecular cloning, expression and catalytic activity of a human AKR7 member of the aldo-keto reductase superfamily: evidence that the major 2-carboxybenzaldehyde reductase from human liver is a homologue of rat aflatoxin B1-aldehyde reductaseX-ray structure of human class IV sigmasigma alcohol dehydrogenase. Structural basis for substrate specificityExcessive vitamin A toxicity in mice genetically deficient in either alcohol dehydrogenase Adh1 or Adh3Genetic evidence that retinaldehyde dehydrogenase Raldh1 (Aldh1a1) functions downstream of alcohol dehydrogenase Adh1 in metabolism of retinol to retinoic acidAlcohol dehydrogenase-catalyzed in vitro oxidation of anandamide to N-arachidonoyl glycine, a lipid mediator: synthesis of N-acyl glycinals.Distinct retinoid metabolic functions for alcohol dehydrogenase genes Adh1 and Adh4 in protection against vitamin A toxicity or deficiency revealed in double null mutant miceClinically significant pharmacokinetic drug interactions with benzodiazepines.The predicted impact of reducing the nicotine content in cigarettes on alcohol useCytochrome P450 2E1: its clinical and toxicological role.Pharmacokinetic interaction of abacavir (1592U89) and ethanol in human immunodeficiency virus-infected adultsThe role of pharmacogenetically-variable cytochrome P450 enzymes in drug abuse and dependence.Toxicological interactions between alcohol and benzodiazepines.Alcohol drinking as an unfavorable prognostic factor for male patients with nasopharyngeal carcinoma.Association between in vivo alcohol metabolism and genetic variation in pathways that metabolize the carbon skeleton of ethanol and NADH reoxidation in the alcohol challenge twin study.CYP2E1 and risk of chemically mediated cancers.Lifetime alcohol intake is associated with an increased risk of KRAS+ and BRAF-/KRAS- but not BRAF+ colorectal cancer.Bacteriocolonic pathway for ethanol oxidation: characteristics and implications.Differential induction of ethanol-metabolizing CYP2E1 and nicotine-metabolizing CYP2B1/2 in rat liver by chronic nicotine treatment and voluntary ethanol intake.Characterisation of a novel mouse liver aldo-keto reductase AKR7A5.Effect of zinc on hepatic drug metabolism under ethanol toxicity.
P2860
Q21245066-54F325CC-060F-47A4-87AE-1C1FC64D7510Q24313464-D318DA69-AAF5-46F7-BB8F-6D0BFC057D3DQ24318491-1F9A97D1-3808-4645-B2FB-D2A66E76260BQ28508999-B66C2A90-7A9D-4FA3-A5C1-678350953A59Q28587546-3B9198A0-CB44-4553-81D2-16B21B858316Q33560137-4ED8BA16-41D8-438A-A852-41159205A2FDQ33705853-4AC7B854-5B73-496C-822D-23B9FD8115E8Q33785867-7D24511D-06DE-4ABC-A33A-298E3E9E3299Q33949792-236DC97C-722A-485B-85AB-6490241089E7Q33962207-C2FCDC88-4900-48A7-A308-9702BFD5FB6AQ33979817-B2FFBEE1-071D-44EF-8AC5-0EF87CA8DDB6Q34612112-94A1C9D4-0F8B-4DE3-A929-E97351CA6D30Q34624505-F7981DD7-599F-4701-96C3-BAEBE9261C27Q36499706-FF563CA3-30E4-4750-8FEB-CB11DFE64BA4Q37060131-DA8B7BEE-0DB8-4E6B-9068-AAFB4A2CDB03Q37674595-CC74AA8B-D926-4BAE-A9A9-1BCE1222589DQ39102623-42492092-6A3F-421D-BF13-DDFDC200DEEBQ41114732-9387A815-DF17-452A-AD80-CA8963D1CBFAQ41929123-7D1ED6C8-09BC-498C-9D0B-195824040AC6Q44068396-5290536B-56D4-4FC6-93D5-31070800A53FQ46831538-677094B0-C633-4A1C-954C-F487B94E77E9
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Mechanisms of ethanol-drug-nutrition interactions.
@en
Mechanisms of ethanol-drug-nutrition interactions.
@nl
type
label
Mechanisms of ethanol-drug-nutrition interactions.
@en
Mechanisms of ethanol-drug-nutrition interactions.
@nl
prefLabel
Mechanisms of ethanol-drug-nutrition interactions.
@en
Mechanisms of ethanol-drug-nutrition interactions.
@nl
P2860
P1476
Mechanisms of ethanol-drug-nutrition interactions.
@en
P2093
P2860
P304
P356
10.3109/15563659409017974
P577
1994-01-01T00:00:00Z